Plus therapeutics awarded $17.6 million from state of texas

Funding from the cancer prevention and research institute of texas (cprit), the second largest global public funder of cancer research, will support the majority of the development costs of 186 rnl for leptomeningeal metastases.
pstv Ratings Summary
pstv Quant Ranking